Skip to main content Accessibility help
×
Home

Are randomised controlled trials the only gold that glitters?

  • Mike Slade (a1) and Stefan Priebe (a2)
  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Are randomised controlled trials the only gold that glitters?
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Are randomised controlled trials the only gold that glitters?
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Are randomised controlled trials the only gold that glitters?
      Available formats
      ×

Abstract

  • An abstract is not available for this content so a preview has been provided below. To view the full text please use the links above to select your preferred format.

Copyright

Corresponding author

Mike Slade, Institute of Psychiatry, De Crespigny Park, Denmark Hill, London SE5 8AF, UK

References

Hide All
Burns, T., Fahy, T., Thompson, S., et al (1999) Intensive case management for severe psychotic illness (letter). Lancet, 354, 13851386.
Duggan, L., Fenton, M., Dardennes, R. M., et al (1999) Olanzapine for schizophrenia. Cochrane Library, Issue 3. Oxford: Update Software
Gil body, S. & Song, F. (2000) Publication bias and the integrity of psychiatry research. Psychological Medicine, 30, 253258.
Hoffmann, K., Isermann, M., Kaiser, W., et al (2000) Quality of life in the course of deinstitutionalisation – Part IV of the Berlin deinstitutionalisation study (in German). Psychiatrische Praxis, 27, 183188.
Lehman, A. & Steinwachs, D. (1998) Transating research into practice: the Schizophrenia Patient Outcomes Research Team (PORT) treatment recommendations. Schizophrenia Bulletin, 24, 110.
Priebe, S. & Slade, M. (2001) Evidence in Mental Health Care. London: Routledge (in press).
Roth, A. & Fonagy, P. (1996) What Works for Whom? London: Guilford Press.
Taylor, D. (1996) Through the minefield: how to decide which drug to use and when. Schizophrenia Monitor, 6, 15.
Thornicroft, G., Strathdee, G., Phelan, M., et al (1998) Rationale and design. PRiSM Psychosis Study I. British Journal of Psychiatry, 173, 363370.
Thornicroft, G., Becker, T., Holloway, F., et al (1999) Community mental health teams: evidence or belief? British journal of Psychiatry 175, 508513.

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed

Are randomised controlled trials the only gold that glitters?

  • Mike Slade (a1) and Stefan Priebe (a2)
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *